Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01698424 · ClinicalTrials.gov registry record

PET/CT of Skeletal Muscle Amino Acid Kinetics

A clinical trial of Sarcopenia, sponsored by University of California, San Francisco.

Completed
Registry status
12
Enrollment target
1
Study location

NCT01698424 is a study of Sarcopenia that has completed, run by University of California, San Francisco. The registered enrollment target is 12 participants, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01698424, a study of Sarcopenia, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
12 participants
Enrollment target
1
Study location

Study Summary

Our goal is to develop and test a new imaging technique to help scientists study sarcopenia, the process by which muscle becomes weaker with age. This imaging technique uses Positron Emission Tomography/Computed Tomography (PET/CT) scanners to measure the ability of muscle to synthesize new protein. This ability to build new muscle protein is known as the Protein Synthesis Rate, and is thought to decline as people age and to contribute to muscle weakening. We are researching this technique in order to develop a tool to help scientists and physicians better understand how muscle ages and how it changes based on some stimulus, such as when people eat a high protein meal, exercise, or take muscle-building drugs. If our research is successful, it will provide a new method for scientists and physicians to test the effectiveness of new drugs and other treatments for muscle weakness. The study will look for healthy woman between the ages of 65 and 80.

Conditions Studied

Study Locations (1)

California

  • Imaging Center-Department of Radiology, UCSF - San Francisco

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2013-06
Est. Completion 2014-09

What the Registry Record Tells You About NCT01698424

The ClinicalTrials.gov registry entry for NCT01698424 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (85% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 0 interventions.

NCT01698424 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01698424 about?

NCT01698424 is a clinical study titled "PET/CT of Skeletal Muscle Amino Acid Kinetics". Our goal is to develop and test a new imaging technique to help scientists study sarcopenia, the process by which muscle becomes weaker with age. This imaging technique uses Positron Emission Tomography/Computed Tomography (PET/CT) scanners to measure the ability of muscle to synthesize new protein....

What is the current status of trial NCT01698424?

This trial is currently completed. The enrollment target is 12 participants. The study started on 2013-06. Estimated completion is 2014-09.

What conditions does trial NCT01698424 study?

This clinical trial studies the following conditions: Sarcopenia.

Who is sponsoring clinical trial NCT01698424?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01698424 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.